Sfoglia per Autore ORINI, STEFANIA
Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease
2018-01-01 Agosta, F.; Altomare, D.; Festari, C.; Orini, S.; Gandolfo, F.; Boccardi, M.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Nestor, P.; Nobili, F.; Walker, Z.; Pagani, M.
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia
2018-01-01 Nestor, P. J.; Altomare, D.; Festari, C.; Drzezga, A.; Rivolta, J.; Walker, Z.; Bouwman, F.; Orini, S.; Law, I.; Agosta, F.; Arbizu, J.; Boccardi, M.; Nobili, F.; Frisoni, G. B.
Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia
2018-01-01 Boccardi, M.; Festari, C.; Altomare, D.; Gandolfo, F.; Orini, S.; Nobili, F.; Frisoni, G. B.; Agosta, F.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Nestor, P.; Walker, Z.
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia
2018-01-01 Walker, Z.; Gandolfo, F.; Orini, S.; Garibotto, V.; Agosta, F.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Nestor, P.; Boccardi, M.; Altomare, D.; Festari, C.; Nobili, F.
Clinical utility of FDG-PET for the clinical diagnosis in MCI
2018-01-01 Arbizu, J.; Festari, C.; Altomare, D.; Walker, Z.; Bouwman, F.; Rivolta, J.; Orini, S.; Barthel, H.; Agosta, F.; Drzezga, A.; Nestor, P.; Boccardi, M.; Frisoni, G. B.; Nobili, F.
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus
2018-01-01 Nobili, F.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Agosta, F.; Nestor, P.; Walker, Z.; Boccardi, M.; Festari, C.; Altomare, D.; Gandolfo, F.; Orini, S.
Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders
2018-01-01 Nobili, F.; Festari, C.; Altomare, D.; Agosta, F.; Orini, S.; Van Laere, K.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Nestor, P.; Walker, Z.; Boccardi, M.
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia
2018-01-01 Bouwman, F.; Orini, S.; Gandolfo, F.; Altomare, D.; Festari, C.; Agosta, F.; Arbizu, J.; Drzezga, A.; Nestor, P.; Nobili, F.; Walker, Z.; Morbelli, S.; Boccardi, M.
Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease
2018-01-01 Drzezga, A.; Altomare, D.; Festari, C.; Arbizu, J.; Orini, S.; Herholz, K.; Nestor, P.; Agosta, F.; Bouwman, F.; Nobili, F.; Walker, Z.; Frisoni, G. B.; Boccardi, M.
Clinical Guidelines: A Crossroad of Many Research Areas. Challenges and Opportunities in Process Mining for Healthcare
2019-01-01 Gatta, R.; Vallati, M.; Fernandez-Llatas, C.; Martinez-Millana, A.; Orini, S.; Sacchi, L.; Lenkowicz, J.; Marcos, M.; Munoz-Gama, J.; Cuendet, M.; de Bari, B.; Marco-Ruiz, L.; Stefanini, A.; Castellano, M.
What role can process mining play in recurrent clinical guidelines issues? A position paper
2020-01-01 Gatta, R.; Vallati, M.; Fernandez-Llatas, C.; Martinez-Millana, A.; Orini, S.; Sacchi, L.; Lenkowicz, J.; Marcos, M.; Munoz-Gama, J.; Cuendet, M. A.; de Bari, B.; Marco-Ruiz, L.; Stefanini, A.; Valero-Ramon, Z.; Michielin, O.; Lapinskas, T.; Montvila, A.; Martin, N.; Tavazzi, E.; Castellano, M.
On the Comparison of Markov Chains-based Models in Process Mining for Healthcare: A Case Study
2023-01-01 Vallati, M.; Orini, S.; Lorusso, M.; Savino, M.; Gatta, R.; Filosto, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease | 1-gen-2018 | Agosta, F.; Altomare, D.; Festari, C.; Orini, S.; Gandolfo, F.; Boccardi, M.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Nestor, P.; Nobili, F.; Walker, Z.; Pagani, M. | |
| Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia | 1-gen-2018 | Nestor, P. J.; Altomare, D.; Festari, C.; Drzezga, A.; Rivolta, J.; Walker, Z.; Bouwman, F.; Orini, S.; Law, I.; Agosta, F.; Arbizu, J.; Boccardi, M.; Nobili, F.; Frisoni, G. B. | |
| Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia | 1-gen-2018 | Boccardi, M.; Festari, C.; Altomare, D.; Gandolfo, F.; Orini, S.; Nobili, F.; Frisoni, G. B.; Agosta, F.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Nestor, P.; Walker, Z. | |
| Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia | 1-gen-2018 | Walker, Z.; Gandolfo, F.; Orini, S.; Garibotto, V.; Agosta, F.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Nestor, P.; Boccardi, M.; Altomare, D.; Festari, C.; Nobili, F. | |
| Clinical utility of FDG-PET for the clinical diagnosis in MCI | 1-gen-2018 | Arbizu, J.; Festari, C.; Altomare, D.; Walker, Z.; Bouwman, F.; Rivolta, J.; Orini, S.; Barthel, H.; Agosta, F.; Drzezga, A.; Nestor, P.; Boccardi, M.; Frisoni, G. B.; Nobili, F. | |
| European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus | 1-gen-2018 | Nobili, F.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Agosta, F.; Nestor, P.; Walker, Z.; Boccardi, M.; Festari, C.; Altomare, D.; Gandolfo, F.; Orini, S. | |
| Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders | 1-gen-2018 | Nobili, F.; Festari, C.; Altomare, D.; Agosta, F.; Orini, S.; Van Laere, K.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Nestor, P.; Walker, Z.; Boccardi, M. | |
| Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia | 1-gen-2018 | Bouwman, F.; Orini, S.; Gandolfo, F.; Altomare, D.; Festari, C.; Agosta, F.; Arbizu, J.; Drzezga, A.; Nestor, P.; Nobili, F.; Walker, Z.; Morbelli, S.; Boccardi, M. | |
| Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease | 1-gen-2018 | Drzezga, A.; Altomare, D.; Festari, C.; Arbizu, J.; Orini, S.; Herholz, K.; Nestor, P.; Agosta, F.; Bouwman, F.; Nobili, F.; Walker, Z.; Frisoni, G. B.; Boccardi, M. | |
| Clinical Guidelines: A Crossroad of Many Research Areas. Challenges and Opportunities in Process Mining for Healthcare | 1-gen-2019 | Gatta, R.; Vallati, M.; Fernandez-Llatas, C.; Martinez-Millana, A.; Orini, S.; Sacchi, L.; Lenkowicz, J.; Marcos, M.; Munoz-Gama, J.; Cuendet, M.; de Bari, B.; Marco-Ruiz, L.; Stefanini, A.; Castellano, M. | |
| What role can process mining play in recurrent clinical guidelines issues? A position paper | 1-gen-2020 | Gatta, R.; Vallati, M.; Fernandez-Llatas, C.; Martinez-Millana, A.; Orini, S.; Sacchi, L.; Lenkowicz, J.; Marcos, M.; Munoz-Gama, J.; Cuendet, M. A.; de Bari, B.; Marco-Ruiz, L.; Stefanini, A.; Valero-Ramon, Z.; Michielin, O.; Lapinskas, T.; Montvila, A.; Martin, N.; Tavazzi, E.; Castellano, M. | |
| On the Comparison of Markov Chains-based Models in Process Mining for Healthcare: A Case Study | 1-gen-2023 | Vallati, M.; Orini, S.; Lorusso, M.; Savino, M.; Gatta, R.; Filosto, M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile